The buzz reheated Friday around a possible media mega-merger, helping lift shares of the companies involved, while a report from a short seller sent shares of a medical device manufacturer sharply low... ...

Deep-pocketed investors have adopted a bearish approach towards DexCom DXCM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DXCM usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 53 extraordinary options activities for DexCom. This level ...

Medtronic plc (NYSE:MDT) is included among the Best Stocks for a Dividend Stock Portfolio. Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025 Medtronic plc (NYSE:MDT), one of the leading names in medical devices, has faced some challenges in recent years but has taken measures to address them, with a particular emphasis on strengthening profitability. In the past, the company considered spinning off certain divisions and ultimately decided to separate its diabetes care segment. T ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive session on Thursday, shedding 6.93 percent to close at $3.09 apiece as investor sentiment was dampened by a potential dilution from a fundraising program that could deliver the company worth $63 million. In a statement earlier this week, Microbot Medical Inc. (NASDAQ:MBOT) said it was able to raise $25.2 mi ...

Key Takeaways SGHT announced a published meta-analysis validating OMNI's long-term safety and efficacy.SGHT's OMNI was shown to reduce IOP and medication use with durable outcomes.SGHT reported that nearly 89% of patients achieved at least 20% IOP reduction at 6, 12 and 24 months.Sight Sciences (SGHT) recently announced the publication of a systematic literature review and meta-analysis in the European Journal of Ophthalmology, highlighting the long-term safety and efficacy of the OMNI Surgical System (OMNI ...

产品发布与定价策略 - 公司推出支持房颤筛查及多项健康指标监测的上臂式电子血压计KSY3610和臂筒式电子血压计KSY8600 [1] - 新品KSY3610系列定价259元起 将高端血压监测技术带入两百元级市场 [1] - 定价策略体现科技普惠理念 可能重塑家用医疗设备市场竞争格局 [1] 技术优势与产品特性 - 产品采用双传感器+人工智能算法捕捉柯氏音变化 测量精准度与水银血压计一致 [2] - 技术对房颤、心律不齐、低血压等特殊人群适用 有效避免漏诊误诊 [2] - 创新整合房颤筛查功能 支持单次测量同时完成血压测量和房颤筛查 [2] - 搭载自研医养大模型AI 用户可通过智能APP获得健康问题专业解答 [2] 市场背景与发展趋势 - 中国加入《关于汞的水俣公约》 要求2026年起全面禁止含汞血压计生产使用 [3] - 血压计行业呈现院内器械家用化、家用器械线上化趋势 [3] - 2022-2025年京东血压计行业复合增速约18.6% [3] - 带房颤筛查和心电监测产品及柯氏音电子血压计产品表现突出 [3] 公司战略与竞争优势 - 通过技术突破和工艺优化实现高功能低价格产品策略 [2] - 构建硬件+软件+服务模式 形成健康领域生态优势 [2] - 将医疗级监测技术下放至消费级市场 通过规模化生产和生态服务价值挖掘构建新盈利模式 [3]

 Toronto, Ontario – TheNewswire - (September 19, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce the successful completion of its annual audit under the Medical Device Single Audit Program (MDSAP), ISO 13485 Quality Management System, and EU Medical Device Regulation (MDR) requirements by Notified Body. The audit resulted in zero major nonconformities and confirmed Ventripoint Diagnostics Ltd.’s continued compliance with global quality and ...

It’s an exciting time to be a growth investor despite the current volatility.Thanks to modern brokerages, it’s easier and cheaper than ever to access a wide range of global stocks. With so many options at your fingertips, the possibilities are vast – but so is the noise.The internet is flooded with data, opinions, and analysis, making it difficult to zero in on truly promising growth stocks. Add in the constant barrage of headlines from business news outlets, and it’s easy to feel overwhelmed.That’s why sta ...

MINNEAPOLIS and BRISBANE, Australia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that after convening its Special Meeting of Stockholders (the “Special Meeting”) virtually on Thursday, September 18, 2025, at 5:00 p.m. Central time (being 8:00 a.m. AEST on Friday, Sep ...

U.S. medical device maker GE Healthcare is working with advisers to explore options for its China unit including an outright sale, a person with knowledge of the discussions said on Friday. ...